Cancer BiologybioRxivPreprint
Macrophage proliferation machinery leads to PDAC progression, but susceptibility to innate immunotherapy.
D. G. DeNardo, C. Zuo, J. M. Baer…·J. D. Weber
This study shows that TAM proliferation in PDAC is driven by CSF1 from fibroblasts, leading to immunosuppression and tumor progression, but also increasing sensitivity to CD40 agonist therapy.